Clinical trial
Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
NCT00117533 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00117533 |
|---|---|
| Title | Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta |
| Official title | A Pilot Study to Evaluate the Efficacy and Safety of Pegylated Interferon Alfa-2b Plus Ribavirin in the Treatment of Patients With Dual Chronic Hepatitis B and Delta |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | National Health Research Institutes, Taiwan National Science and Technology Council, Taiwan |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B, Chronic Hepatitis D |
| Intervention type | Drug |
| Interventions | pegylated IFN alfa-2b plus ribavirin |
| Enrollment | 20 |
| Start date | Sep 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Jul 7, 2005 |
| Last update posted | May 25, 2006 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: